Virtual Investor is a leading platform providing investors with direct access to innovative companies, management teams and thought leaders.

Featured Event:
5 for ’25

Featured Companies

Covered Companies

Covered Companies

Series

What This Means

Featuring: American Resources
March 7, 2025

Mark Jensen, CEO of American Resources Corporation and ReElement Technologies Corporation, discussed the Company’s production of rare earth elements and how American Resources is working to cost-effectively develop in-demand minerals for defense.

What This Means

Featuring: PalisadeBio
March 4, 2025

Dr. Joerg Heyer, Head of Translational Science and Medicine of Palisade Bio highlights preclinical data for lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis (UC)

What This Means

Featuring: Sonnet BioTherapeutics
February 19, 2025

Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline Drug Candidates

What This Means

Featuring: Aim ImmunoTech
February 11, 2025

Tom Equels, CEO of AIM ImmunoTech and Professor Casper H.J. van Eijck, MD, PhD, Pancreato-biliary Surgeon at Erasmus MC, discuss the Phase 1b/2 clinical trial involving AIM’s Ampligen® (rintatolimod) and AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab) in the treatment of late-stage pancreatic cancer (“DURIPANC”)

Past Events

Past Events

Join Us

Sign up for email alerts to stay up-to-date on the latest Virtual Investor events


By submitting this form, you are consenting to receive marketing emails from: Virtual Investor. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

If you are interested in joining our roster of covered companies and participating in our events, sign up here: